Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
>
Neuroprotection Program
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
Neuroprotection Program
16-Oct-2024
NYR Completes Safety Studies Ahead of Phase I Clinical Trial
7-Oct-2024
Brain Injury Program GLP Studies Further Update 6
27-Sep-2024
Brain Injury Program GLP Studies Further Update 5
9-Sep-2024
Brain Injury Program GLP Studies Further Update 4
20-Aug-2024
Brain Injury Program GLP Studies Further Update No 3
6-Aug-2024
Brain Injury Program GLP Studies Further Update
16-Jul-2024
GLP Studies Update
26-Jun-2024
NYR Signs Strategic Partnership with US Brain Injury Company
30-Apr-2024
Nyrada Commences Walter Reed Traumatic Brain Injury Study
28-Mar-2024
Nyrada Commences Key Brain Injury Program Preclinical Study
28-Feb-2024
Significant Neuroprotection in NYR Preclinical Brain Injury
9-Jun-2023
Brain Injury Program Preclinical Development Update
18-Jan-2023
Collaboration with Walter Reed and UNSW Extended to 2025
11-Jan-2023
Brain Injury Program Update
6-Jun-2022
Brain Injury Program Target Unveiled and Phase I Update
29-Mar-2022
New Drug Offers Potential Oral Treatment for Concussion
4-Jan-2022
Brain Injury Program Update and Pathway to Phase I
15-Jun-2021
Improved Drug Candidate Selected for WRAIR Studies
1-Feb-2021
NYR Secures Collaboration with Walter Reed and UNSW
15-Jul-2020
Nyrada Brain Injury Drug Pharmacokinetic Study Results
9-Jul-2020
Nyrada Brain Injury Data Published by Premier US Military Health Conference
25-May-2020
Milestone Achieved in the Nyrada Brain Injury Program